Status:
COMPLETED
Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Study of the efficacy and tolerance of Motens® (lacidipine) in patients with essential hypertension. To obtain information on the dosage used in practice and the tolerance at the start of treatment (1...
Eligibility Criteria
Inclusion
- Non-hospitalised patients of both sexes aged 18 years or more with essential hypertension requiring treatment according to the recommendations of the German League for Hypertension
Exclusion
- Patients who had the contraindications listed in the product information (the case report file contained a copy of the product information)
Key Trial Info
Start Date :
June 1 1998
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
24526 Patients enrolled
Trial Details
Trial ID
NCT02235415
Start Date
June 1 1998
Last Update
September 10 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.